Skip to main content
Equibles

Cinctive Capital Management LP

Position in FTRE — Fortrea Holdings Inc.

CIK 1787258 New York, NY
Back to FTRE Full portfolio

Position in FTRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,934,075
+$1,173,609 QoQ
Shares Held
168,625
-9.8% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#67
of 334 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FTRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cinctive Capital Management LP holds $203,047,008 across 45 Biotechnology names. FTRE ranks #19 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 APGE
Apogee Therapeutics, Inc.
 350,165 $46,477,400
2 INSM
INSMED Inc
 161,996 $17,272,013
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 26,712 $13,268,651
4 CYTK
Cytokinetics Inc
 137,838 $11,742,419
5 ROIV
Roivant Sciences Ltd.
 226,140 $8,003,094
6 NTHI
Neonc Technologies Holdings, Inc.
 1,607,464 $7,281,811
7 ERAS
Erasca, Inc.
 391,642 $7,174,881
8 KRYS
Krystal Biotech, Inc.
 16,367 $6,083,122

All Filings in FTRE

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,934,075 168,625
2026-03-31 $1,760,466 186,886